Rituximab

Материал из WikiSyktSU
Перейти к: навигация, поиск

Rituximab, offered under the manufacturer name Rituxan among other folks, is a medication utilized to take care of specified autoimmune ailments and varieties of cancer.[3] It is employed for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-optimistic mucocutaneous ulcers.[3][four][five][6] It is presented by gradual injection into a vein.[three]

Common side outcomes, which often happen inside of two hrs of the treatment being given, consist of rash, itchiness, minimal blood strain, and shortness of breath.[3] Other significant aspect outcomes consist of reactivation of hepatitis B in these beforehand contaminated, progressive multifocal leukoencephalopathy, and harmful epidermal necrolysis.[3][7] It is unclear if use during pregnancy is secure for the [https://pearson.instructure.com/eportfolios/79910/Home/Rituximab_Precio_Mexico

rituximab precio] developing fetus or new child baby.[three][2]

Rituximab is a chimeric monoclonal antibody from the protein CD20, which is primarily found on the surface area of immune system B cells.[eight] When it binds to this protein it triggers cell demise.[3]

Rituximab was authorized for medical use in 1997.[eight] It is on the Globe Health Organization's Checklist of Crucial Medicines.[9] The patent expired in 2016, and a number of biosimilars have been released